The House Energy and Commerce Health Subcommittee has scheduled a hearing for March 10 on "Drug Safety: An Update from the FDA." At the hearing, the FDA will detail its current challenges and successes in the area of drug safety.  Joshua M. Sharfstein, M.D., FDA Principal Deputy Commissioner, is slated to testify.